Informações:
Falhas:
ID
29738
Descrição
A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT00703118
Link
https://clinicaltrials.gov/show/NCT00703118
Palavras-chave
Versões (1)
- 17/04/2018 17/04/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
17 de abril de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Hepatitis C, Chronic NCT00703118
Eligibility Hepatitis C, Chronic NCT00703118
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C, Chronic NCT00703118
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Chronic Hepatitis C HCV genotype determination | Hepatitis C virus RNA assay
Item
patient must have chronic hepatitis c infection (genotype 1) with hcv rna level >= 1000 iu/ml
boolean
C0524910 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
C1272251 (UMLS CUI [2])
C1533728 (UMLS CUI [1,2])
C1272251 (UMLS CUI [2])
PEGINTERFERON/RIBAVIRIN Course Quantity failed
Item
patient must have failed at least 1 prior course of peg-ifn/rbv therapy (standard treatment)
boolean
C1875630 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,4])
C0750729 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,4])
Contraceptive methods Quantity Willing
Item
patient must be willing to use 2 effective methods of birth control for up to 7 months after last dose of study medication
boolean
C0700589 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0600109 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,2])
C0600109 (UMLS CUI [1,3])
Patient Unresponsive to Treatment | Viral Breakthrough
Item
patient is a previous non-responder that is classified as a viral breakthrough case
boolean
C0030705 (UMLS CUI [1,1])
C0205269 (UMLS CUI [1,2])
C4053869 (UMLS CUI [2])
C0205269 (UMLS CUI [1,2])
C4053869 (UMLS CUI [2])
Hepatitis C HCV genotype determination | Subtype Quantity
Item
patient is infected with hepatitis c virus, genotype 1, exhibiting more than one subtype
boolean
C0019196 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
C0449560 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1533728 (UMLS CUI [1,2])
C0449560 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Hepatitis C virus genotype determination | Coinfection Hepatitis C virus genotype determination
Item
patient has hepatitis c virus, genotype 1, and exhibits co-infection with any other genotype
boolean
C1533728 (UMLS CUI [1])
C0275524 (UMLS CUI [2,1])
C1533728 (UMLS CUI [2,2])
C0275524 (UMLS CUI [2,1])
C1533728 (UMLS CUI [2,2])
Decompensated liver disease
Item
evidence of decompensated liver disease
boolean
C4075847 (UMLS CUI [1])
Condition Requirement CORTICOSTEROIDS FOR SYSTEMIC USE
Item
patient has condition that requires use of systemic corticosteroids
boolean
C0348080 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C3653708 (UMLS CUI [1,3])
C1514873 (UMLS CUI [1,2])
C3653708 (UMLS CUI [1,3])